Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ed P. F. Yzerman is active.

Publication


Featured researches published by Ed P. F. Yzerman.


Emerging Infectious Diseases | 2002

A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999.

Jeroen W. Den Boer; Ed P. F. Yzerman; Joop Schellekens; Kamilla D. Lettinga; H.C. Boshuizen; Jim E. van Steenbergen; A Bosman; Susan van den Hof; Hans van Vliet; Marcel F. Peeters; Ruud J. van Ketel; Peter Speelman; Jacob L. Kool; Marina A.E. Conyn-van Spaendonck

In 1999, an outbreak of Legionnaires’ disease affected many visitors to a flower show in the Netherlands. To identify the source of the outbreak, we performed an environmental investigation, as well as a case-control study among visitors and a serologic cohort study among exhibitors to measure exposure to possible sources. Of 77,061 visitors, 188 became ill (133 confirmed and 55 probable cases), for an attack rate of 0.23% for visitors and 0.61% for exhibitors. Two whirlpool spas in halls 3 and 4 of the exhibition and a sprinkler in hall 8 were culture positive for Legionella pneumophila. One of three genotypes found in both whirlpool spas was identical to the isolates from 28 of 29 culture-positive patients. Persons who paused at the whirlpool spa in hall 3 were at increased risk for becoming ill. This study illustrates that whirlpool spas may be an important health hazard if disinfection fails.


Emerging Infectious Diseases | 2002

Legionnaires' Disease at a Dutch Flower Show: Prognostic Factors and Impact of Therapy

Kamilla D. Lettinga; Annelies Verbon; Gerrit-Jan Weverling; Joop Schellekens; Jeroen W. Den Boer; Ed P. F. Yzerman; Jacobus Prins; Wim G. Boersma; Ruud J. van Ketel; Jan M. Prins; Peter Speelman

After a large outbreak of Legionnaires’ disease in the Netherlands, we determined risk factors for intensive care unit (ICU) admission and death and the impact of adequate therapy on ICU-free survival among 141 hospitalized patients. Overall mortality rate was 13%, and ICU mortality rate was 36%. Smoking, temperature >38.5°C, and bilateral infiltrates shown on chest x-ray were independent risk factors for ICU admission or death (all p<0.05). Starting adequate therapy within 24 hours after admission resulted in a higher ICU-free survival rate compared to therapy initiation after 24 hours: 78% versus 54%, respectively (p=0.005). However, delay in providing therapy to patients with urinary antigen tests with negative results did not influence outcome. These data suggest that by using the urinary antigen test on admission a more tailored approach to patients with community-acquired pneumonia may be applied.


BMC Genomics | 2010

Comparative genome analysis of a large Dutch Legionella pneumophila strain collection identifies five markers highly correlated with clinical strains

Ed P. F. Yzerman; Jeroen W. Den Boer; Martien P. M. Caspers; Arpit A. Almal; Bill Worzel; Walter van der Meer; Roy Christiaan Montijn; Frank Schuren

BackgroundDiscrimination between clinical and environmental strains within many bacterial species is currently underexplored. Genomic analyses have clearly shown the enormous variability in genome composition between different strains of a bacterial species. In this study we have used Legionella pneumophila, the causative agent of Legionnaires disease, to search for genomic markers related to pathogenicity. During a large surveillance study in The Netherlands well-characterized patient-derived strains and environmental strains were collected. We have used a mixed-genome microarray to perform comparative-genome analysis of 257 strains from this collection.ResultsMicroarray analysis indicated that 480 DNA markers (out of in total 3360 markers) showed clear variation in presence between individual strains and these were therefore selected for further analysis. Unsupervised statistical analysis of these markers showed the enormous genomic variation within the species but did not show any correlation with a pathogenic phenotype. We therefore used supervised statistical analysis to identify discriminating markers. Genetic programming was used both to identify predictive markers and to define their interrelationships. A model consisting of five markers was developed that together correctly predicted 100% of the clinical strains and 69% of the environmental strains.ConclusionsA novel approach for identifying predictive markers enabling discrimination between clinical and environmental isolates of L. pneumophila is presented. Out of over 3000 possible markers, five were selected that together enabled correct prediction of all the clinical strains included in this study. This novel approach for identifying predictive markers can be applied to all bacterial species, allowing for better discrimination between strains well equipped to cause human disease and relatively harmless strains.


Human Immunology | 2009

Deficient mannose-binding lectin-mediated complement activation despite mannose-binding lectin–sufficient genotypes in an outbreak of Legionella pneumophila pneumonia

Bjorn L. Herpers; Ed P. F. Yzerman; Ben A.W. de Jong; Jacob P. Bruin; Kamilla D. Lettinga; Saskia Kuipers; Jeroen W. Den Boer; Erik J. van Hannen; Ger T. Rijkers; Heleen van Velzen-Blad; Bartelt M. de Jongh

Polymorphisms leading to deficiency of mannose-binding lectin (MBL) are associated with predisposition to infection. However, MBL deficiency can be protective against intracellular pathogens that use MBL to enter host cells. The role of MBL genotype and activity in infection with the intracellular pathogen Legionella pneumophila was studied in a large outbreak of legionellosis at a Dutch flower show. A total of 141 patients, 65 exposed asymptomatic exhibition staff members and 670 unexposed blood bank donors were included for the study of MBL2 genotypes and MBL-mediated complement activation. Genotypic MBL deficiency was equally prevalent in patients and controls. Deficient MBL-mediated complement activation was more prevalent in patients. Even in patients with genotypes that confer MBL sufficiency, 20.6% lacked MBL-mediated complement activation. In most patients with MBL-sufficient genotypes who lacked MBL-mediated activation at the acute phase of disease, lectin pathway functionality was restored at convalescence. In conclusion, genotypic MBL deficiency was not a risk factor for legionellosis. However, patients with legionellosis displayed deficient MBL-mediated complement activation even with MBL-sufficient genotypes. Together, these genotypical and functional data suggest that the observed deficiency of lectin pathway activation is an effect of legionellosis rather than a risk factor for acquiring it.


Clinical Microbiology and Infection | 2008

Genotypic comparison of clinical Legionella isolates and patient‐related environmental isolates in The Netherlands, 2002–2006

J. W. Den Boer; Jacob P. Bruin; L.P.B. Verhoef; K. Van der Zwaluw; Ruud Jansen; Ed P. F. Yzerman


Clinical Microbiology and Infection | 2007

Legionnaires' disease and gardening

J. W. Den Boer; Ed P. F. Yzerman; Ruud Jansen; Jacob P. Bruin; L.P.B. Verhoef; G. Neve; K. Van der Zwaluw


International Journal of Hygiene and Environmental Health | 2007

Outbreak detection and secondary prevention of Legionnaires' disease: A national approach

Jeroen W. Den Boer; L.P.B. Verhoef; Max A. Bencini; Jacob P. Bruin; Ruud Jansen; Ed P. F. Yzerman


Journal of Medical Microbiology | 2007

Sensitivity of Legionella pneumophila DNA detection in serum samples in relation to disease severity.

Bram M. W. Diederen; Jacob P. Bruin; Jeroen W. Den Boer; Marcel F. Peeters; Ed P. F. Yzerman


Archives of Environmental & Occupational Health | 2005

A Case of Legionnaires' Disease Caused by Aspiration of Ice Water

Max A. Bencini; Ed P. F. Yzerman; Rutger H. T. Koornstra; Catharina C. M. Nolte; Jeroen W. Den Boer; Jacob P. Bruin


Journal of Medical Microbiology | 2006

Sensitivity of three serum antibody tests in a large outbreak of Legionnaires' disease in the Netherlands.

Ed P. F. Yzerman; Jeroen W. Den Boer; Kamilla D. Lettinga; Arnoud J Schel; Joop Schellekens; Marcel F. Peeters

Collaboration


Dive into the Ed P. F. Yzerman's collaboration.

Top Co-Authors

Avatar

Jacob P. Bruin

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. W. Den Boer

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Max A. Bencini

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar

Ruud Jansen

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge